Christoph T Berger (C T Berger)

ORCID

Publication Activity (10 Years)

Years Active: 2015-2023
Publications (10 Years): 18

Top Venues

RMD open

Arthritis & rheumatology (Hoboken, N.J.)

Annals of the rheumatic diseases

NPJ vaccines

Universität Basel Departement Biomedizin

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Universität Basel Departement Biomedizin Apr 1o 2014

Switzerland

Research Group Leader :: Translational Immunology Lab

Publications

Andrea Katharina Hemmig, Markus Aschwanden, Sabine Seiler, Christoph T Berger, Philipp Köhn, Diego Kyburz, Noemi Mensch, Daniel Staub, Mihaela Stegert, Stephan Imfeld, Thomas Daikeler
Long delay from symptom onset to first consultation contributes to permanent vision loss in patients with giant cell arteritis: a cohort study. RMD open 9 (1) (2023)
Andrea Katharina Hemmig, Markus Aschwanden, Sabine Seiler, Christoph T Berger, Philipp Köhn, Diego Kyburz, Noemi Mensch, Daniel Staub, Mihaela Stegert, Stephan Imfeld, Thomas Daikeler
Long delay from symptom onset to first consultation contributes to permanent vision loss in patients with giant cell arteritis: a cohort study. RMD open 9 (1) (2023)
Noemi Mensch, Andrea Katharina Hemmig, Markus Aschwanden, Stephan Imfeld, Mihaela Stegert, Mike Recher, Daniel Staub, Diego Kyburz, Christoph T Berger, Thomas Daikeler
Rapid glucocorticoid tapering regimen in patients with giant cell arteritis: a single centre cohort study. RMD open 9 (3) (2023)
Andrea Katharina Hemmig, Markus Aschwanden, Stephan Imfeld, Christoph T Berger, Thomas Daikeler
Can the 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis be used for diagnosis? Arthritis & rheumatology (Hoboken, N.J.) (2023)
Andrea Katharina Hemmig, Markus Aschwanden, Sabine Seiler, Christoph T Berger, Philipp Köhn, Diego Kyburz, Noemi Mensch, Daniel Staub, Mihaela Stegert, Stephan Imfeld, Thomas Daikeler
Long delay from symptom onset to first consultation contributes to permanent vision loss in patients with giant cell arteritis: a cohort study. RMD open 9 (1) (2023)
Andrea Katharina Hemmig, Markus Aschwanden, Sabine Seiler, Christoph T Berger, Philipp Köhn, Diego Kyburz, Noemi Mensch, Daniel Staub, Mihaela Stegert, Stephan Imfeld, Thomas Daikeler
Long delay from symptom onset to first consultation contributes to permanent vision loss in patients with giant cell arteritis: a cohort study. RMD open 9 (1) (2023)
Julia R Hirsiger, Maria Martinez, Dimitrios A Tsakiris, Micol G Cittone, Lukas Graf, Johannes Oldenburg, Behnaz Pezeshkpoor, Mike Recher, Jens Mueller, Bernhard Gerber, Christoph T Berger
Investigating potential mechanisms underlying FVIII inhibition in acquired hemophilia A associated with mRNA COVID-19 vaccines. Journal of thrombosis and haemostasis : JTH 20 (4) (2022)
Stephan Imfeld, Delia Scherrer, Noemi Mensch, Markus Aschwanden, Daniel Staub, Christoph T Berger, Thomas Daikeler, Christof Rottenburger
A Simplified PET/CT Measurement Routine with Excellent Diagnostic Accuracy for the Diagnosis of Giant Cell Arteritis. Diagnostics (Basel, Switzerland) 12 (3) (2022)
Patricia Baenziger-Sieber, Thomas Daikeler, Simona Negoias, Christoph T Berger
Throat swelling following tocilizumab infusion-not always angioedema. Rheumatology advances in practice 5 (3) (2021)
Marc A Meier, Christoph T Berger
A simple clinical score to identify likely hepatitis B vaccination non-responders - data from a retrospective single center study. BMC infectious diseases 20 (1) (2020)
Christoph T Berger, Thomas Daikeler
Longitudinal versus cross-sectional IL-6 measurements in tocilizumab-treated GCA. Response to: 'Analysis of IL-6 measurement in GCA patients treated with tocilizumab should consider concomitant treatment with prednisone' by Samson and Bonnotte. Annals of the rheumatic diseases 79 (8) (2019)
Christoph T Berger, Birke Rebholz-Chaves, Mike Recher, Tobias Manigold, Thomas Daikeler
Serial IL-6 measurements in patients with tocilizumab-treated large-vessel vasculitis detect infections and may predict early relapses. Annals of the rheumatic diseases 78 (7) (2019)
Julia R Hirsiger, Philipp S Fuchs, Peter Häusermann, Bojana Müller-Durovic, Thomas Daikeler, Mike Recher, Hans H Hirsch, Luigi Terracciano, Christoph T Berger
Syphilis Reactivates Latent Epstein-Barr Virus Reservoir via Toll-Like Receptor 2 and B-Cell Receptor Activation. Open forum infectious diseases 6 (9) (2019)
Tim Bühler, Noemi Boos, Anne B Leuppi-Taegtmeyer, Christoph T Berger
Febrile illness and bicytopenia within hours after tick-borne encephalitis booster vaccination. NPJ vaccines 4 (2019)
Mike Recher, Julia R Hirsiger, Marc B Bigler, Martin Iff, Barbara Lemaître, Kathrin Scherer, Peter Häusermann, Claire-Anne Siegrist, Christoph T Berger
Immune system correlates of extensive limb swelling in response to conjugated pneumococcal vaccination. NPJ vaccines 3 (2018)
Marc B Bigler, Julia R Hirsiger, Mike Recher, Matthias Mehling, Thomas Daikeler, Christoph T Berger
Varicella zoster virus-specific T cell responses in untreated giant cell arteritis: comment on the article by England et al. Arthritis & rheumatology (Hoboken, N.J.) 70 (2) (2017)
M Elkuch, V Greiff, Christoph T Berger, M Bouchenaki, T Daikeler, A Bircher, A A Navarini, I Heijnen, M Recher
Low immunoglobulin E flags two distinct types of immune dysregulation. Clinical and experimental immunology 187 (3) (2017)
Christoph T Berger, Anuska Llano, Jonathan M Carlson, Zabrina L Brumme, Mark A Brockman, Samandhy Cedeño, P Richard Harrigan, Daniel E Kaufmann, David Heckerman, Andreas Meyerhans, Christian Brander
Immune screening identifies novel T cell targets encoded by antisense reading frames of HIV-1. Journal of virology 89 (7) (2015)

Christoph T Berger.css-eqlu8i{font-size:small;padding-left:4px;} (C T Berger)

Publication Activity (10 Years)

Top Topics

Top Venues

Christoph T Berger (C T Berger)